Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Company Info
Contact Transposon Therapeutics
Transposon Therapeutics
Drug Discovery & Development
Overview
Contact US
Contributions
Contributors
Contributions
0 Contributors
1 / 0
No authors found
1 / 0
2 Contributions
1 / 1
Novel Nucleoside
Transposon Therapeutics Acquired a Portfolio of Novel Nucleoside Analogs for Oncology To Enhance Development Pipeline
Transposon Therapeutics
PR-11-24-NI-119
Nov 21, 2024
Clinical Trials
Transposon to Present Results from Phase 2 Study for the Treatment of ALS/FTD at the 7th Annual ALS ONE Research Symposium
Transposon Therapeutics
PR-10-24-NI-79
Nov 7, 2024
1 / 1
